CN
1345-25-1
应用筛选条件
关键词:'1345-25-1'
显示 1-19 共 19 条结果 关于 "1345-25-1" 范围 技术文档
Quality Control Range Sheet- HCMB-117 and HCMB-217
Control II 17 - 35 ng/mL
Osteonectin Control I 60 - 124 ng/mL
Control II 647 - 1345 ng/mL
Periostin Control I 6.5 - 13
Product Information Sheet - M4264
Instructions
This product is soluble in water (25 mg/ml) and in
methanol (25 mg/ml), yielding a clear, colorless
solution in both instances.
References
1. Chang, K. J., et al., Morphiceptin (NH4-Tyr-Pro
Quality Control Ranges: Milliplex Non-Human Primate Cytokine Magnetic Bead Panel II
FGF-2 Control 1 118 - 246 pg/mL IL-1α Control 1 238 - 495 pg/mL
Control 2 648 - 1345 pg/mL Control 2 1170 - 2430 pg/mL
Data Sheet - S2437
Biochem., 57, 443-478
(1988).
4. Broudy, V.C., Stem cell factor and hematopoiesis.
Blood, 90, 1345-1364 (1997).
5. Kitamura, T., et al., Establishment and
characterization of a unique human cell
Data Sheet - S2562
. EMBO J., 6, 3341-3351 (1987).
4. Broudy, V.C., Stem cell factor and hematopoiesis.
Blood, 90, 1345-1364 (1997).
5. Kitamura, T., et al., Establishment and
characterization of a unique human cell
SBR00030 Technical Bulletin
to host
physiology: short-chain fatty acids as key bacterial
metabolites. Cell, 165(6), 1332-1345 (2016).
2. Cummings, J.H., et al., Short chain fatty acids in
human large intestine, portal
Novabiochem Letters 01/03
Botti, et al. (1996) J. Am. Chem. Soc., 118, 10018.
11. T. D. Pallin & J. P. Tam (1996) Chem. Commun., 1345.
12. J. C. Spetzler & T. Hoeg-Jensen (2001) J. Pept. Sci., 7, 537.
13. D. Bonnet, et al. (2000) Tetrahedron
Novabiochem Letters 02/06
al. (1998) J. Pept. Sci., 4, 195.
3. a) A. S. Dutta (1989) Chem. Br., 25, 159. ; b) K. D. Kopple (1972) J. Pharm. Sci., 61,
1345.
4. H. F. Brugge, et al. (1994) Int. J. Peptide Protein Res.
Novabiochem Letters 02/03
lipopeptides [20 - 23], peptide-DNA [24],
peptide-glycopeptide conjugates [25 - 27], and Lys-dendrimers [28]
(Figure 1).
Fig. 1: Oxime and hydrazone ligation (X=O, NH).
Usually the hydroxylamine or
Periodic table Poster
3d54s1
25
54.938
1246
2061
1.60
Mn
-1, 0, 2, 3, 4, 6, 7
[Ar] 3d54s2
26
55.845
1538
2861
1.64
Fe
-2, 0, 2, 3, 6
[Ar] 3d64s2
27
58.933
Periodic table A4
3d54s1
25
54.938
1246
2061
1.60
Mn
-1, 0, 2, 3, 4, 6, 7
[Ar] 3d54s2
26
55.845
1538
2861
1.64
Fe
-2, 0, 2, 3, 6
[Ar] 3d64s2
27
58.933
Protocol: Porcine Insulin RIA Kit
18 1860 1863 1294 18.4
19 200
µU/mL
1345
20 1229 1287 718 10.2
Controls/Unknown
Reprint: Size-Exclusion Chromatography for Preparative Purification of Biomolecules
, Chem. Eng. Technol. 28, 1335–1345
(2005).
13. D.A. Horneman, et al., AIChE J. 53 (6),
1441–1449 (2007).
14. P.J. Naish and S. Hartwell, Chromatographia 26 (1) 285–
296 (1988).
15. Quantification
S&E Campaign Lab Tools - Tables for laboratory use
29 63.546 8.92 g/cm3 1084.62 2562 127.8 1.75 1.90 1, 2 [Ar] 3d10 4s1 0.01 7.7264 +0.340 V (II),
+0.521 V (I)
Curium Cm 96 247.07* 13.51 g/cm3 1345 - 174.4 ~1.20 - 3, 4 [Rn]
Product Information Sheet - HPFM2
Gene Name
Entrez
Gene ID
COX6C cytochrome c oxidase subunit VIc 1345
CTNNB1 catenin (cadherin-associated protein) beta 1 88kDa 1499
CYLD cylindromatosis (turban tumor syndrome) 1540
DDB2
Strategies for Enhancing the Accumulation and Retention of Extracellular Matrix in Tissue-Engineered Cartilage Cultured in Bioreactors
scaffolds on chondrogenesis in vitro: dynamic pore reduction
promotes cartilage formation. Tissue Eng 12: 1345–1355.
44. Häuselmann HJ, Aydelotte MB, Schumacher BL, Kuettner KE, Gitelis SH,
et al. (1992
Building blocks for peptide synthesis
Ltd., Birmingham, 1998, pp. 339.
59. a) A. S. Dutta (1989) Chem. Br., 25, 159. ;
b) K. D. Kopple (1972) J. Pharm. Sci., 61, 1345.
60. H. F. Brugge, et al. (1994) Int. J. Peptide Protein Res., 43, 166.
Katalog neoLab
sterile filter for DURO A8 25 x 61 mm
3-1347 sterile filter for DURO A6 25 x 143 mm 2 pcs./pack
3-1348 sterile filter for DURO A4 25 x 255 mm 2
XP725 Worksheet for Lot Number 071M4826
6 8 Anti CY3/5 C0992
1345 8 1 1 1 SKM1 S9568
1346 8 1 1 2 SKM1 S9568
1347 8 1 1 3 Beta tubulin III (neuronal) S5308
1348 8 1 1 4 Beta tubulin III (neuronal) S5308
1349